Effect of Remimazolam on Postoperative Delirium in Older Adult Patients Undergoing Orthopedic Surgery: A Prospective Randomized Controlled Clinical Trial
Jin-Jin Yang,Lei Lei,Di Qiu,Sai Chen,Li-Ka Xing,Jing-Wei Zhao,Yuan-Yuan Mao,Jian-Jun Yang
DOI: https://doi.org/10.2147/DDDT.S392569
2023-01-20
Abstract:Jin-Jin Yang, 1, 2 Lei Lei, 1, 2 Di Qiu, 1 Sai Chen, 1 Li-Ka Xing, 1 Jing-Wei Zhao, 1 Yuan-Yuan Mao, 1, 2 Jian-Jun Yang 1, 2 1 Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China; 2 Henan Province International Joint Laboratory of Pain, Cognition and Emotion, Zhengzhou, People's Republic of China Correspondence: Jian-Jun Yang, Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, No. 1 East Jianshe Road, Zhengzhou, People's Republic of China, Tel +8613783537619, Email Background: Postoperative delirium is common in older adult patients and associated with a poor prognosis. The use of benzodiazepine was identified as an independent risk factor for delirium, but there is no randomized controlled trial regarding the relationship between remimazolam, a new ultra-short acting benzodiazepine, and postoperative delirium. We designed a randomized controlled trial to evaluate if remimazolam increases the incidence of postoperative delirium compared with propofol in older adult patients undergoing orthopedic surgery with general anesthesia. Patients and Methods: We enrolled 320 patients aged more than 60 with American Society of Anesthesiologists physical status I–III who underwent orthopedic surgery. Patients were randomized to two groups to receive intraoperative remimazolam or propofol, respectively. Our primary outcome was the incidence of delirium within 3 days after surgery. Secondary outcome was emergence quality including the incidence of emergence agitation, extubation time, and length of post-anesthesia care unit (PACU) stay. Adverse events were also recorded. Results: The incidence of postoperative delirium was 15.6% in the remimazolam group and 12.4% in the propofol group (Risk ratio, 1.26; 95% CI, 0.72 to 2.21; Risk difference, 3.2%; 95% CI, − 4.7% to 11.2%; P = 0.42). No significant differences were observed for time of delirium onset, duration of delirium, and delirium subtype between the two groups. Patients in remimazolam group had a lower incidence of hypotension after induction and consumed less vasoactive drugs intraoperatively, but had a longer postoperative extubation time and PACU stay. Conclusion: General anesthesia with remimazolam was not associated with an increased incidence of postoperative delirium compared with propofol in older adult patients undergoing orthopedic surgery. Keywords: benzodiazepines, delirium, older adults, orthopedic surgery, propofol, remimazolam Postoperative delirium (POD) is a common complication in older adult patients after anesthesia and surgery, with an estimated incidence of 10–50% depending on the type of surgery. 1,2 Patients with POD have an increased risk of postoperative complications and mortality. 3,4 The causes of POD are multifactorial, including predisposing and precipitating factors. Among them, perioperative medication, especially benzodiazepines, had gained attention as a critical and potentially intervenable factor of POD. 5,6 Remimazolam, a new ultra-short acting benzodiazepine, was recently approved for procedural sedation and general anesthesia. 7–9 Its metabolism is mainly induced by tissue esterase, independent of liver and kidney function, and its metabolites are inactive. 10,11 Besides, incidences of injection pain and cardiovascular and respiratory depression were less with remimazolam than propofol. Based on these characteristics, remimazolam appears to be an ideal intravenous anesthetic for the older surgical patients. However, previous studies showed that benzodiazepines can increase the risk of POD. 12–14 Guidelines from the American Geriatrics Society 15 and other organizations 16,17 also recommend minimization of benzodiazepines exposure for older surgical patients. As a new benzodiazepine, there are only two newly published observational studies regarding the association of remimazolam with POD. 18,19 Therefore, whether remimazolam could increase the incidence of POD in older adult patients remains unclear. Thus, we designed a randomized controlled trial (RCT) to assess the effect of intraoperative use of remimazolam versus propofol on POD in older adult patients undergoing orthopedic surgery. The study was a single-center, patient- and evaluator-blinded RCT, which was approved by the Ethics Review Committee (2021-KY-0843-002) of the First Affiliated Hospital of Zhengzhou University in China. The trial was registered at Chinese ClinicalTrials.gov on Augus -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal